PER-001

N/A

Report date: 2023/07/21 13:47:54
NME

Base Information

Drug NamePER-001
Drug Alias NamePER-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor antagonists
TargetsEndothelin receptor
Therapy Area/IndicationsDiabetic RetinopathyGlaucoma, Open-Angle
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPerfuse Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPerfuse Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDiabetic RetinopathyGlaucoma, Open-Angle
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A